<code id='977B0D61F8'></code><style id='977B0D61F8'></style>
    • <acronym id='977B0D61F8'></acronym>
      <center id='977B0D61F8'><center id='977B0D61F8'><tfoot id='977B0D61F8'></tfoot></center><abbr id='977B0D61F8'><dir id='977B0D61F8'><tfoot id='977B0D61F8'></tfoot><noframes id='977B0D61F8'>

    • <optgroup id='977B0D61F8'><strike id='977B0D61F8'><sup id='977B0D61F8'></sup></strike><code id='977B0D61F8'></code></optgroup>
        1. <b id='977B0D61F8'><label id='977B0D61F8'><select id='977B0D61F8'><dt id='977B0D61F8'><span id='977B0D61F8'></span></dt></select></label></b><u id='977B0D61F8'></u>
          <i id='977B0D61F8'><strike id='977B0D61F8'><tt id='977B0D61F8'><pre id='977B0D61F8'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:6922
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Patients, digital health players weigh in on FTC's data privacy plan
          Patients, digital health players weigh in on FTC's data privacy plan

          AdobeThisyearhasseentheFederalTradeCommissioncrackdownondigitalhealthcompanies’irresponsibledatause.

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          A deep dive into Applied Therapeutics’ data, and questions on Cassava

          MollyFerguson/STATHaveyouheardthenews?I’mlaunchingaweeklyemailnewsletterstartingonMarch28.It’scalled